Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes
MetadataShow full item record
Aims: To investigate (i) optimal intensity (four visits vs. six visits) and duration (6 vs. 12 months) of the Diabetes Medication Assistance Service in community pharmacy and (ii) sustainability of improvements in patients’ diabetes control associated with differing intensities of intervention. Methods: A national quota sample of 90 community pharmacies in Australia were randomly assigned into group 1 (6-month Diabetes Medication Assistance Service) or group 2 (12-month Diabetes Medication Assistance Service) and subsequently recruited a total of 524 patients. A wide range of clinical (HbA1c, blood pressure, lipids) and quality-of-life outcome measures were assessed.Results: The 6- and 12-month Diabetes Medication Assistance Service resulted in significant and similar reductions in HbA1c (−0.9 mmol/mol; 95% CI −0.7 to −1.1) –, total cholesterol (−0.3 mmol/l; 95% CI −0.1 to −0.4) and triglycerides (−0.3 mmol/l; 95% CI −0.1 to −0.5). There was also a significant reduction in the number of patients who were at risk of having a cardiovascular event in the next 10 years. For the subset of patients for whom data were available at baseline, completion and 18 months, improvements in HbA1c and total cholesterol were sustained at 18 months and triglycerides showed a further improvement at 18 months. Conclusions: The Diabetes Medication Assistance Service resulted in significant improvements in diabetes control that were independent of intensity and duration of the service and showed evidence of being sustained at 18 months. The extent and sustainability of clinical improvements achieved by the Diabetes Medication Assistance Service, together with the resulting reduction in cardiovascular risk, should translate into future cost savings to healthcare systems by delaying and reducing diabetes-related complications.
Showing items related by title, author, creator and subject.
Clifford, Rhonda (2004)People with diabetes mellitus are more likely to die from cardiovascular causes than those without diabetes, and modifiable risk factors, such as hyperglycaemia, dyslipidaemia and hypertension can be targeted in intervention ...
Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist surveyWibowo, Y.; Parsons, Richard; Sunderland, Bruce; Hughes, Jeff (2015)Background: Diabetes is an emerging chronic disease in developing countries. Currently the management of diabetes in developing countries is mainly hospital or clinic based. With burgeoning numbers of patients with diabetes, ...
Improving health outcomes by preventing intensive care related infection in Malaysia Intensive Care Unit (INVEST study)Soh, Kim Lam (2012)Ventilator-associated pneumonia (VAP), catheter-related blood stream infection (CRBSI) and pressure ulcers (PU) are well recognized complications in intensive care units (ICUs). Many of these are preventable but can also ...